Updates are available Correction dated 2018-12-07
Click to view Correction: https://doi.org/10.1186/s13195-018-0446-z
-
Authors
Freedman, Morris http://orcid.org/0000-0003-4003-6158
Leach, Larry
Carmela Tartaglia, M.
Stokes, Kathryn A.
Goldberg, Yael
Spring, Robyn
Nourhaghighi, Nima
Gee, Tom
Strother, Stephen C.
Alhaj, Mohammad O.
Borrie, Michael
Darvesh, Sultan
Fernandez, Alita
Fischer, Corinne E.
Fogarty, Jennifer
Greenberg, Barry D.
Gyenes, Michelle
Herrmann, Nathan
Keren, Ron
Kirstein, Josh
Kumar, Sanjeev
Lam, Benjamin
Lena, Suvendrini
McAndrews, Mary Pat
Naglie, Gary
Partridge, Robert
Rajji, Tarek K.
Reichmann, William
Uri Wolf, M.
Verhoeff, Nicolaas P. L. G.
Waserman, Jordana L.
Black, Sandra E.
Tang-Wai, David F.
-
Funding
Funding for this research was provided by:
Toronto Dementia Research Alliance Partner Institutions
Department of Medicine Alternative Funding Plan and Division of neurology Innovation Fund, University of Toronto
Edwards Family Foundation
Ontario Neurodegenerative Disease Research Initiative (ONDRI) funded by Ontario Brain Institute
- License Information
-
More Information
Article History
Received: 25 January 2018
Accepted: 8 May 2018
First Online: 18 July 2018
Change Date: 7 December 2018
Change Type: Correction
Change Details: Upon publication of this article [1], it was brought to our attention that one of the 303 participants in the normative study should have been deleted from the database.
Authors' information
: Tom Gee is now at Indoc Research, Toronto, ON, Canada. Barry D. Greenberg is now at Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
: The study was approved by the Research Ethics Board at Baycrest Health Sciences. Written informed consent was obtained from all participants.
: MF received financial support for a Behavioural Neurology fellow from Eli Lilly Canada, served on an advisory board for Eli Lilly Canada, receives royalties for a book on Clock Drawing from Oxford University Press, is listed on a provisional patent related to methods and kits for differential diagnosis of Alzheimer’s disease vs frontotemporal dementia using blood biomarkers, and may be listed on the planned patent application, and serves on the editorial board of Brain and Cognition. LL receives royalties from Pearson Assessment on sales of the Kaplan Baycrest Neurocognitive Assessment (KBNA). NH received research support from Axovant, Lundbeck and Roche, and consultation fees from Merck, Lilly, Mediti and Astellas. SEB reports institutional grants from Pfizer, GE Healthcare, Eli Lilly, Roche, Cognoptix, Biogen, and Novartis and personal honoraria from Pfizer, Eli Lilly, Boehringer Ingelheim, Novartis, Merck, and Medscape (Biogen Idec); SEB also reports salary support from Sunnybrook Research Institute, Brill Chair, Department of Medicine, Sunnybrook Health Sciences Centre. SCS is Chief Science Officer of ADMdx, LLC. MCT, KAS, YG, RS, NN, TG, MOA, MB, SD, AF, CEF, JF, BDG, MG, RK, JK, SK, BL, SL, MPM, GN, RP, TKR, WR, MUW, NPLGV, JLW, and DFT-W do not have any competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
